ID   IOSE-144
AC   CVCL_5533
SY   IOSE144; IOSE 144; NFHIOSE-144
DR   Wikidata; Q54897884
RX   DOI=10.5282/edoc.3898;
RX   PubMed=10329039;
RX   PubMed=15706405;
CC   From: Canadian Ovarian Tissue Bank, University of British Columbia; Vancouver; Canada.
CC   Doubling time: 28 hours (PubMed=10329039).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; SV40 large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Ovary, surface epithelium; UBERON=UBERON_0001304.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 16
//
RX   DOI=10.5282/edoc.3898;
RA   Euer N.I.;
RT   "Identification of target genes for the therapy and diagnosis of
RT   ovarian carcinoma.";
RL   Thesis PhD (2005); Ludwig Maximilians University of Munich; Munich; Germany.
//
RX   PubMed=10329039; DOI=10.1006/gyno.1999.5348;
RA   Kruk P.A., Godwin A.K., Hamilton T.C., Auersperg N.;
RT   "Telomeric instability and reduced proliferative potential in ovarian
RT   surface epithelial cells from women with a family history of ovarian
RT   cancer.";
RL   Gynecol. Oncol. 73:229-236(1999).
//
RX   PubMed=15706405; DOI=10.3892/or.13.3.375;
RA   Euer N.I., Kaul S., Deissler H., Mobus V.J., Zeillinger R.,
RA   Weidle U.H.;
RT   "Identification of L1CAM, Jagged2 and neuromedin U as ovarian
RT   cancer-associated antigens.";
RL   Oncol. Rep. 13:375-387(2005).
//